Literature DB >> 7487823

Motion sickness incidence during a round-the-world yacht race.

M Turner1, M J Griffin.   

Abstract

Motion sickness experiences were obtained from participants in a 9 month, round the world yacht race. Race participants completed questionnaires on their motion sickness experience 1 week prior to the start of the race, during the race, and following the race. Yacht headings, sea states, and wind directions were recorded throughout the race. Illness and the occurrence of vomiting were related to the duration at sea and yacht encounter directions relative to the prevailing wind. Individual crewmember characteristics, the use of anti-motion sickness drugs, activity while at sea, and after-effects of yacht motion were also examined with respect to sickness occurrence. Sickness was greatest among females and younger crewmembers, and among crewmembers who used anti-motion sickness drugs. Sickness varied as a function of drug type and activity while at sea. Crewmembers who reported after-effects of yacht motion also reported greater sickness while at sea. The primary determinants of motion sickness were the duration of time spent at sea and yacht encounter direction to the prevailing wind.

Entities:  

Mesh:

Year:  1995        PMID: 7487823

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  3 in total

1.  Patterns of illness and injury encountered in amateur ocean yacht racing: an analysis of the British Telecom Round the World Yacht Race 1996-1997.

Authors:  C J S Price; T J W Spalding; C McKenzie
Journal:  Br J Sports Med       Date:  2002-12       Impact factor: 13.800

Review 2.  Space motion sickness.

Authors:  James R Lackner; Paul Dizio
Journal:  Exp Brain Res       Date:  2006-10-05       Impact factor: 1.972

3.  Motion sickness diagnostic criteria: Consensus Document of the Classification Committee of the Bárány Society.

Authors:  Yoon-Hee Cha; John F Golding; Behrang Keshavarz; Joseph Furman; Ji-Soo Kim; Jose A Lopez-Escamez; Måns Magnusson; Bill J Yates; Ben D Lawson
Journal:  J Vestib Res       Date:  2021       Impact factor: 2.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.